Autologous Matrix-Induced Chondrogenesis Market contains market size and forecasts of Autologous Matrix-Induced Chondrogenesis (AMIC) in Global, including the following market information:
- Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Autologous Matrix-Induced Chondrogenesis (AMIC) market was valued at 104.6 million in 2021 and is projected to reach US$ 144 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hyaluronic Acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autologous Matrix-Induced Chondrogenesis (AMIC) include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH and Smith & Nephew plc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autologous Matrix-Induced Chondrogenesis (AMIC) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, by Type, 2021 (%)
- Hyaluronic Acid
- Collagen
- Polyethylene Glycol (PEG)
- Polylactic-Co-Glycolic Acid (PGLA)
- Others
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, by Application, 2021 (%)
- Knee Cartilage Repair
- Hip Cartilage Repair
- Elbow Cartilage Repair
- Others
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Autologous Matrix-Induced Chondrogenesis (AMIC) revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Autologous Matrix-Induced Chondrogenesis (AMIC) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Anika Therapeutics, Inc.
- Arthro-Kinetics
- B. Braun Melsungen AG
- BioTissue AG
- CartiHeal
- Geistlich Pharma AG
- JRI Orthopaedics Ltd.
- Matricel GmbH
- Smith & Nephew plc
- Zimmer Biomet Holdings
Industry Market Size
